Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo New York
Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo New York.
Drug Metab Dispos. 2020 Oct;48(10):894-902. doi: 10.1124/dmd.120.000118. Epub 2020 Aug 5.
It has become commonplace (270+ article citations to date) to measure the fraction unbound (FrUn) of drugs in tissue homogenates and diluted plasma and then use a Correction Factor Equation (CFE) to extrapolate to the undiluted state. The CFE is based on assumptions of nonspecific binding with experimental use of very low drug concentrations. There are several possible determinants of apparent nonspecific binding as measured by methods such as equilibrium dialysis: true macromolecule binding and lipid partitioning along with receptor, enzyme, and transporter interactions. Theoretical calculations based on nonlinear protein binding indicate that the CFE will be most reliable to obtain FrUn when added drug concentration is small, binding constants are weak, protein concentrations are relatively high, and tissue dilution is minimal. When lipid partitioning is the sole factor determining apparent tissue binding, the CFE should be perfectly accurate. Use of very low drug concentrations, however, makes it more likely that specific binding to receptors and other targets may occur, and thus FrUn may reflect some binding to such components. Inclusion of trapped blood can clearly cause minor to marked discrepancies from purely tissue binding alone, which can be corrected. Furthermore, assessment of the occurrence of ionization/pH shifts, drug instability, and tissue metabolism may be necessary. Caution is needed in the use and interpretation of results from tissue dilution studies and other assessments of nonspecific binding, particularly for very strongly bound drugs with very small FrUn values and in tissues with metabolic enzymes, receptors, and trapped blood. SIGNIFICANCE STATEMENT: The use of tissue, plasma, and cell preparations to help obtain fraction unbound and tissue-to-plasma partition coefficients in pharmacokinetics has grown commonplace, especially for brain. This report examines theoretical, physiological, and experimental issues that need consideration before trusting such measurements and calculations.
(迄今为止已有 270 多篇文献引用)测定组织匀浆和稀释血浆中药物未结合分数(FrUn)已变得司空见惯,然后使用校正因子方程(CFE)外推至未稀释状态。CFE 基于与实验中使用的非常低药物浓度的非特异性结合的假设。有几种可能的决定因素可以通过平衡透析等方法测量非特异性结合:真正的大分子结合和脂质分配,以及受体、酶和转运体相互作用。基于非线性蛋白结合的理论计算表明,当添加的药物浓度较小、结合常数较弱、蛋白浓度相对较高且组织稀释最小时,CFE 获得 FrUn 的可靠性最高。当脂质分配是唯一决定表观组织结合的因素时,CFE 应该是非常准确的。然而,使用非常低的药物浓度使得与受体和其他靶标发生特异性结合的可能性更大,因此 FrUn 可能反映出与这些成分的一些结合。包含被困血液显然会导致与单纯组织结合相比出现轻微至明显的差异,可以进行校正。此外,评估电离/pH 偏移、药物不稳定性和组织代谢的发生情况可能是必要的。在使用和解释组织稀释研究和其他非特异性结合评估的结果时需要谨慎,特别是对于具有非常小 FrUn 值的非常强结合药物和具有代谢酶、受体和被困血液的组织。重要性声明:使用组织、血浆和细胞制剂来帮助获得药代动力学中的未结合分数和组织-血浆分配系数已经变得司空见惯,尤其是在大脑中。本报告检查了在信任这些测量和计算之前需要考虑的理论、生理和实验问题。